When Do GLP-1 Weight-Loss Drugs Start Working?
There is no guaranteed day when appetite or weight will change. Some people notice a difference early; others need more time. The first few injections are not a reliable test of the final result, particularly while the prescribed dose is being increased.
This short uses a visual metaphor for appetite signals. It does not show a treatment result or predict when weight will change for an individual.
Early appetite changes, weight change and tolerability answer different questions. A useful start is to track all three instead of using one sensation—such as nausea or unusually low hunger—as proof that treatment is working.
At a glance
| Track | Why it helps |
|---|---|
| Injection date and actual dose | Separates calendar time from dose exposure |
| Weight under similar conditions | Makes the trend easier to interpret |
| Appetite, meals and fluids | Distinguishes satiety from difficulty eating |
| Symptoms and daily function | Shows the burden as well as potential benefit |
Escalation is part of treatment, not wasted time
The injection regimens use stepwise escalation to reduce gastrointestinal adverse reactions. [1,2] Do not speed up the schedule to chase an early result or match someone else’s dose. A delay caused by tolerability also changes the context for an effectiveness review. Ask the prescriber which dose and review period are relevant to your treatment goal rather than assuming that every week since the first injection is equivalent.
Describe the experience precisely
A useful note might say: “Four weeks since starting, no missed injections, weight roughly stable, fewer evening snacks, no vomiting.” This is an illustrative record, not a benchmark for a normal response. It gives the care team more to work with than “nothing happened.” Use comparable weighing conditions and discuss a monitoring frequency that is helpful rather than distressing. Short-term water and bowel changes can obscure the trend.
Keep the safety clock separate from the effectiveness clock
You may need weeks or months of observation to assess a treatment plan, but you do not need to wait that long to report a problem. Severe abdominal pain, persistent vomiting or inability to keep fluids down requires prompt advice. [3] Do not skip meals aggressively, add weight-loss products or take extra doses because progress seems slow. Rapid loss accompanied by dehydration or poor intake is not the result to aim for.
Frequently asked questions
No appetite change in week one: is it failing?
That alone does not establish failure. Review the full dose history and trend at the planned appointment.
Should I match a trial’s average in the first month?
No. A long-term trial result is not a first-month target or an individual prediction.
What should I ask at my first review?
Ask whether the current plan is tolerable, what dose and timeframe will be used for assessment, and which symptoms should trigger earlier contact.
Related reading
- Wegovy, Saxenda, Mounjaro and Zepbound: What’s Different?
- Wegovy vs Zepbound: Comparing Benefits, Risks and Practical Fit
- Not Losing Weight on a GLP-1 Drug? Plateau vs Nonresponse
Korean version: 비만주사 효과는 언제부터 나타날까? 초기에 확인할 변화와 평가 시점
Sources
- Wegovy US prescribing information · June 2026
- Zepbound US prescribing information · August 2026
- MedlinePlus: Semaglutide injection
General health information, not an individual diagnosis or prescription. Discuss starting, changing or stopping treatment with your clinician. Seek immediate care for emergencies. Sources checked September 22, 2026; local product rules may differ.
